DNA encoding rantes peptide fragments and methods of treatment with the fragments
US6159711A · kind A · utility
10Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 1997 |
| Grant date | Dec 12, 2000 |
| Priority date | — |
| Expiry date | May 23, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modifications to RANTES can result in the modified polypeptide acting as a RANTES or MIP-1.alpha. antagonist. Such antagonists can be used in therapy to reduce inflammation. They are also useful in studying the properties of RANTES or of MIP-1.alpha..
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.